A Study in Healthy Men to Test How Well Different Doses of BI 1569912 Are Tolerated
Clinical trial NCT04978506 · COMPLETED
Trial details
- NCT number
- NCT04978506
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-03
- Primary completion
- 2024-07-04
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.